President & CEO of ONYX Pharmaceuticals Inc. (ONXX, Financial) N Anthony Coles sells 8,922 shares of ONXX on 04/01/2010 at an average price of $30.1 a share.
Onyx Pharmaceuticals Inc. has a market cap of $1.88 billion; its shares were traded at around $30.08 with a P/E ratio of 54.7 and P/S ratio of 7.5.
ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC.
Onyx Pharmaceuticals Inc. has a market cap of $1.88 billion; its shares were traded at around $30.08 with a P/E ratio of 54.7 and P/S ratio of 7.5.
ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC.
CFO Recent Trades:
- Sell:: CFO Matthew K Fust sold 1,919 shares of ONXX stock on 01/06/2010 at the average price of 29.6, the price of the stock has increased by 1.62% since.
Directors and Officers Recent Trades:
- Sell:: VP, Org Learning, Dvlpmnt & HR Judy A Batlin sold 1,119 shares of ONXX stock on 02/08/2010 at the average price of 28.47, the price of the stock has increased by 5.66% since.
- Sell:: VP, Org Learning, Dvlpmnt & HR Judy A Batlin sold 738 shares of ONXX stock on 01/19/2010 at the average price of 29.96, the price of the stock has increased by 0.4% since.
- Sell:: EVP and Chief Business Officer Laura Brege sold 12,500 shares of ONXX stock on 01/15/2010 at the average price of 30.12, the price of the stock has decreased by 0.13% since.
- Sell:: EVP and Chief Business Officer Laura Brege sold 12,500 shares of ONXX stock on 12/02/2009 at the average price of 30, the price of the stock has increased by 0.27% since.
